Paxman AB (PXMBF)
OTHER OTC:PXMBF
PXMBF Stock Chart & Stats
$3.50
$0.00(0.00%)
At close: 4:00 PM EDT
$3.50
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $3.50
Previous CloseN/A
Volume298.00
Average Volume (3M)0.00
Market Cap
$131.59M
Enterprise Value$1.19B
Total Cash (Recent Filing)$106.09M
Total Debt (Recent Filing)$4.58M
Price to Earnings (P/E)―
Beta-0.12
Next Earnings
Aug 21, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.47
Shares Outstanding23,273,417
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.54
Price to Book (P/B)3.05
Price to Sales (P/S)3.95
P/FCF Ratio-145.60
Enterprise Value/Market Cap9.06
Enterprise Value/Revenue3.55
Enterprise Value/Gross Profit7.25
Enterprise Value/Ebitda41.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.2
Revenue Forecast (FY)$44.50M
Bulls Say, Bears Say
Bulls Say
Recurring Revenue ModelPaxman’s business model generates recurring demand from consumables, service contracts and lease arrangements tied to installed systems. An expanding installed base creates predictable, repeatable revenue and higher customer stickiness, supporting durable cash conversion when utilization is steady.
Strong Revenue Growth HistoryConsistent high revenue growth over recent years indicates successful market adoption of scalp cooling systems and expanding placements. Durable top-line expansion helps build the installed base that underpins consumable and service revenues, improving long-term commercial leverage if growth continues.
Conservative Balance SheetExtremely low debt provides financial flexibility and a buffer during profit or cash-flow volatility. A strong capital base reduces bankruptcy and refinancing risk, enabling continued investment in distribution, training and device placements without immediate pressure from fixed interest obligations.
Bears Say
Profitability DeteriorationThe shift from positive earnings to recent net losses signals structural pressure on margins or rising costs. Sustained negative profitability erodes retained earnings, limits reinvestment capacity, and can force cost cuts or dilution unless operational efficiency or pricing improves to restore durable profitability.
Weakened Cash GenerationNegative operating and free cash flow indicate operations and reinvestment are not self-funding. Persistent cash outflows raise execution risk, may require external financing, and constrain the company’s ability to expand placements or support customers, impacting long-term growth plans if unresolved.
Negative Returns On EquityNegative ROE shows the company is not earning adequate returns on its equity base, implying inefficient capital use. With a large equity cushion, persistent negative ROE diminishes shareholder value creation and could pressure management to change strategy or capital allocation to restore longer-term returns.
Paxman AB News
PXMBF FAQ
What was Paxman AB’s price range in the past 12 months?
Paxman AB lowest stock price was $0.01 and its highest was $3.50 in the past 12 months.
What is Paxman AB’s market cap?
Paxman AB’s market cap is $131.59M.
When is Paxman AB’s upcoming earnings report date?
Paxman AB’s upcoming earnings report date is Aug 21, 2026 which is in 72 days.
How were Paxman AB’s earnings last quarter?
Paxman AB released its earnings results on May 21, 2026. The company reported $0 earnings per share for the quarter, missing the consensus estimate of $0.011 by -$0.011.
Is Paxman AB overvalued?
According to Wall Street analysts Paxman AB’s price is currently Overvalued.
Does Paxman AB pay dividends?
Paxman AB does not currently pay dividends.
What is Paxman AB’s EPS estimate?
Paxman AB’s EPS estimate is 0.04.
How many shares outstanding does Paxman AB have?
Paxman AB has 23,273,417 shares outstanding.
What happened to Paxman AB’s price movement after its last earnings report?
Paxman AB reported an EPS of $0 in its last earnings report, missing expectations of $0.011. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Paxman AB?
Currently, no hedge funds are holding shares in PXMBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Paxman AB
Paxman AB (publ), along with its subsidiaries, specializes in the creation and worldwide sale of the Paxman scalp cooling system, an innovative solution designed to minimize hair loss in patients undergoing chemotherapy. This system is distributed across Europe, the United States, Mexico, Japan, Oceania, various Asian regions, and both South and Central America, primarily serving cancer centers and hospitals. The company is also engaged in a research collaboration agreement with the National University Hospital in Singapore, working towards the development of a portable cooling and compression device. Established in 1996, Paxman AB (publ) is headquartered in Karlshamn, Sweden.
PXMBF Earnings Call
Q1 2026
0:00 / 0:00